Description

tert-Butyl 3-Formyl-5,6-Dihydroimidazo[1,2-A]Pyrazine-7(8H)-Carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused heterocyclic structure. This compound is of significant value for medicinal chemistry research and development, serving as a critical building block for the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the development of innovative therapeutic agents. The product is supplied with stringent quality control to ensure batch-to-batch consistency for demanding synthetic applications.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex drug candidates, particularly those targeting neurological and oncological pathways.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Synthesis: Employed in the multi-step synthesis of final active pharmaceutical ingredients requiring the imidazopyrazine core.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry and developing new synthetic methodologies.

Basic Information

Product Name	tert-Butyl 3-Formyl-5,6-Dihydroimidazo[1,2-A]Pyrazine-7(8H)-Carboxylate
CAS No.	1781529-76-7
Molecular Formula	C₁₂H₁₇N₃O₃
Molecular Weight	251.28 g/mol
Synonyms	7-(tert-Butoxycarbonyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-3-carboxaldehyde; tert-Butyl 3-formyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-7-carboxylate; 7-Boc-3-formyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine; 1781529-76-7; BOC-Imidazopyrazine-carboxaldehyde; Imidazo[1,2-a]pyrazine-3-carboxaldehyde, 5,6,7,8-tetrahydro-7-[(1,1-dimethylethoxy)carbonyl]-
EINECS	Contact for details

Quality Control

Our tert-Butyl 3-Formyl-5,6-Dihydroimidazo[1,2-A]Pyrazine-7(8H)-Carboxylate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity, purity, and conformity to established specifications. We provide a detailed Certificate of Analysis (COA) with every shipment, ensuring full traceability and compliance with the rigorous standards required for pharmaceutical R&D and cGMP starting material applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is easily oxidized and should be stored under an inert atmosphere (e.g., nitrogen or argon) for long-term stability. Keep the container tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.